Clinicians should think twice before prescribing DPP-4 inhibitors for diabetes

Research output: Contribution to journalEditorial

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)81-82
Number of pages2
JournalEvidence-Based Medicine
Volume21
Issue number3
DOIs
StatePublished - Jun 1 2016

Fingerprint

Dipeptidyl-Peptidase IV Inhibitors
Hypoglycemic Agents
Diabetes Mellitus

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Clinicians should think twice before prescribing DPP-4 inhibitors for diabetes. / Fenton, Joshua J.

In: Evidence-Based Medicine, Vol. 21, No. 3, 01.06.2016, p. 81-82.

Research output: Contribution to journalEditorial

@article{5bd69c9265cd48e1b4282f968e71cb36,
title = "Clinicians should think twice before prescribing DPP-4 inhibitors for diabetes",
author = "Fenton, {Joshua J}",
year = "2016",
month = "6",
day = "1",
doi = "10.1136/ebmed-2016-110436",
language = "English (US)",
volume = "21",
pages = "81--82",
journal = "Evidence-Based Medicine",
issn = "1356-5524",
publisher = "BMJ Publishing Group",
number = "3",

}

TY - JOUR

T1 - Clinicians should think twice before prescribing DPP-4 inhibitors for diabetes

AU - Fenton, Joshua J

PY - 2016/6/1

Y1 - 2016/6/1

UR - http://www.scopus.com/inward/record.url?scp=84964886989&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964886989&partnerID=8YFLogxK

U2 - 10.1136/ebmed-2016-110436

DO - 10.1136/ebmed-2016-110436

M3 - Editorial

VL - 21

SP - 81

EP - 82

JO - Evidence-Based Medicine

JF - Evidence-Based Medicine

SN - 1356-5524

IS - 3

ER -